We welcome interest from academic research institutions and commercial companies seeking access to our proprietary RNAi and delivery technology platform or to our therapeutic pipeline.
• We are keen to support academic research into RNA therapeutics through access to our materials
• One of very few companies able to provide human-validated RNAi to academics
• Also supply proven delivery systems for use with short interfering RNA or messenger RNA, in vivo
• Comprehensive RNAi platform for diverse range of therapeutic areas, particularly vascular and endothelial
Contact us for more information or with a proposal, here.
Some of our current research collaborators include: Hannover Medical School, Marien Hospital Herne University of Bochum, University Medicine Rostock, VU University Medical Centre Amsterdam, University of Birmingham, Oxford University, Cambridge University and Imperial College London.
Some of our industry partners have included Quark, AstraZeneca and miReven.